# Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

> clinical trial · VERIFIED · 2026-07-30

Status: TERMINATED · Sponsor: Unity Health Toronto · Condition: Major Depressive Disorder(MDD)

- Company: Unity Health Toronto
- Sector: Major Depressive Disorder(MDD)
- Primary source: https://clinicaltrials.gov/study/NCT06843187

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.